Fluticasone-Vilanterol Regimen Tied to Lower Risk for COPD Exacerbations (FREE)

By Kelly Young Edited by David G. Fairchild, MD, MPH Combination fluticasone furoate-vilanterol is associated with reduced risk for chronic obstructive pulmonary disease (COPD) exacerbations. The results of the industry-conducted, open-label study were presented at the European …

http://ift.tt/2bP8mnZ